[After-care examinations in Hodgkin's disease. Internal medicine and chemotherapy].
D000359:Aftercare; D001761:Bleomycin / Q000627:therapeutic use; D001799:Blood Sedimentation; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005340:Fibrinogen; D006689:Hodgkin Disease / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011677:Punctures; D011877:Radionuclide Imaging; D014750:Vincristine / Q000627:therapeutic use
D001761:Bleomycin; D011344:Procarbazine; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D005340:Fibrinogen; D011241:Prednisone
Nachsorgeuntersuchungen bei Morbus Hodgkin. Innere Medizin und Chemotherapie